Worked examples for 50 mg and 100 mg vials, including syringe-unit conversions, are set out in the GHK-Cu dosing protocol
If your side effects have not cleared up and you increase your dose, you'll likely double down and have worse side effects
These antibodies are used to treat a variety of solid and blood tumors and include anti-CTLA-4 antibodies (ipilimumab), anti-PD-1 antibodies (nivolumab, pembrolizumab), and anti-PD-L1 antibodies (atezolizumab, durvalumab, avelumab)
Consulting a doctor is crucial before starting any of these medications to determine suitability and discuss potential side effects
The SUSTAIN-6 trial further highlighted the cardiovascular benefits of Semaglutide, showing a reduction in major adverse cardiovascular events, a critical consideration given the high cardiovascular risk associated with diabetes